Persistent Thrombin Generation During Heparin Therapy in
Patients With Acute Coronary Syndromes
by Piera Angelica Merlini, Diego Ardissino, Kenneth A. Bauer, Luigi Oltrona, Antonio
Pezzano, Biancamaria Bottasso, Robert D. Rosenberg, and Pier Mannuccio
Mannucci
Arterioscler Thromb Vasc Biol
Volume 17(7):1325-1330
July 1, 1997
Copyright © American Heart Association, Inc. All rights reserved.
Distribution of prothrombin fragment 1+2 levels in the plasma sample drawn before the
occurrence of an adverse outcome event in patients with an adverse outcome and those
measured in the plasma drawn at the corresponding time point from patients who did not
develop any event. •, Patients with unstable angina; ♦, patients with myocardial infarction.
Piera Angelica Merlini et al. Arterioscler Thromb Vasc Biol.
1997;17:1325-1330
Copyright © American Heart Association, Inc. All rights reserved.
Distribution of fibrinopeptide A levels in the plasma sample drawn before the occurrence of an
adverse outcome event in patients with an adverse outcome and those measured in the plasma
drawn at the corresponding time point from patients who did not develop any event. •, Patients
with unstable angina; ♦, patients with myocardial infarction.
Piera Angelica Merlini et al. Arterioscler Thromb Vasc Biol.
1997;17:1325-1330
Copyright © American Heart Association, Inc. All rights reserved.